Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public.

about

Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public.

Item

http://www.wikidata.org/entity/Q54257592

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Willingness-to-pay and prefere ...... nd the Chinese general public.

@en

Willingness-to-pay and prefere ...... nd the Chinese general public.

@nl

type

Item

label

Willingness-to-pay and prefere ...... nd the Chinese general public.

@en

Willingness-to-pay and prefere ...... nd the Chinese general public.

@nl

prefLabel

Willingness-to-pay and prefere ...... nd the Chinese general public.

@en

Willingness-to-pay and prefere ...... nd the Chinese general public.

@nl

P1476

Willingness-to-pay and prefere ...... nd the Chinese general public.

@en

P2093

Eric Finkelstein

http://www.w3.org/2001/XMLSchema#string

Joshua Jun Wen Low

http://www.w3.org/2001/XMLSchema#string

Kee Seng Chia

http://www.w3.org/2001/XMLSchema#string

Muhammad Assad Farooqui

http://www.w3.org/2001/XMLSchema#string

Yee Wei Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of the warfarin dose with clinical and pharmacogenetic data.

Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante.

Willingness to pay as a measure of health benefits.

Evaluation of genetic factors for warfarin dose prediction

A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives.

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.

Choice experiments in health: the good, the bad, the ugly and toward a brighter future.

Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

P304

127-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PME.12.124

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hwee Lin Wee

Sze Ling Chan

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29758845

http://www.w3.org/2001/XMLSchema#string